Related Experiment Video

Updated: Aug 20, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

[Can we be infected with atherosclerosis?]

Ewa Rusiecka1

  • 1Katedra i Zakład Patomorfologii UM w Lodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|January 5, 2005
PubMed

Insights

Infectious agents like bacteria and viruses are emerging as significant risk factors for atherosclerosis, a leading cause of death. Research indicates these pathogens may contribute to the development of arterial plaque.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Pathogenesis Research

Context:

  • Atherosclerosis represents a major global health challenge and the primary cause of mortality in Western nations.
  • Conventional risk factors explain only half of atherosclerosis cases, necessitating the exploration of novel contributing factors.
  • Recent research highlights infectious agents as potential contributors to atherogenesis over the past two decades.

Purpose:

  • To investigate the role of bacterial and viral infections as potential risk factors in the development of atherosclerosis.
  • To explore the association between specific pathogens and the pathogenesis of atherosclerosis.
  • To evaluate the evidence supporting an infectious etiology for atherosclerosis.

Summary:

  • Bacterial infections, including Chlamydia pneumoniae and Helicobacter pylori, are implicated in atherosclerosis.
  • Viral infections, particularly from the Herpesviridae family (Cytomegalovirus, Epstein-Barr virus, Herpesvirus), are investigated for their role in atherogenesis.
  • Evidence supporting the infectious theory includes the detection of these pathogens within atheromatous plaques and the presence of specific antibodies in patient blood.

Impact:

  • This research broadens the understanding of atherosclerosis etiology beyond traditional risk factors.
  • Identifying infectious agents as contributors may lead to new diagnostic and therapeutic strategies for atherosclerosis.
  • The findings underscore the importance of considering infectious triggers in cardiovascular disease prevention and management.

More Related Videos

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model05:35

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...